NASDAQ: DCOY
Decoy Therapeutics Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their DCOY stock forecasts and price targets.

Forecast return on equity

Is DCOY forecast to generate an efficient return?

Forecast return on assets

Is DCOY forecast to generate an efficient return on assets?

DCOY revenue forecast

What is DCOY's revenue in the next 1 years based on estimates from 3 analysts?

Avg 1 year Forecast
$12.1M

DCOY vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
DCOY$0.82N/AN/A
GOVX$0.17$6.00+3,514.46%Strong Buy
IMRN$0.85N/AN/A
GNPX$2.20N/AN/A
VIVS$1.92N/AN/A

Decoy Therapeutics Stock Forecast FAQ

What is DCOY's revenue growth forecast for 2026-2026?

(NASDAQ: DCOY) Decoy Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Decoy Therapeutics's revenue in 2026 is $0.

In 2026, DCOY is forecast to generate $71,008,562 in revenue, with the lowest revenue forecast at $68,224,028 and the highest revenue forecast at $73,095,497.

If you're new to stock investing, here's how to buy Decoy Therapeutics stock.

What is DCOY's forecast return on assets (ROA) for 2026-2026?

(NASDAQ: DCOY) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 14.36%.

What is DCOY's forecast return on equity (ROE) for 2026-2026?

(NASDAQ: DCOY) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.